InvestorsHub Logo
Followers 21
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Saturday, 01/26/2019 4:51:04 PM

Saturday, January 26, 2019 4:51:04 PM

Post# of 39
A drug that activates the protein LAG-3 (Lymphocyte Activation Gene-3) used to increase immune response to tumors and treat end-stage breast cancer.
Eftilagimod alpha (LAG-3Ig or IMP321)

https://thehealthhorizon.com/showcases/innovations/846297b8-898f-43bd-99c9-4c843a4f8cbf

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.